Skip to main content
Search

Cardiovascular prevention in type 2 diabetes

Published on June 11, 2013   72 min

A selection of talks on Clinical Practice

Please wait while the transcript is being prepared...
0:00
Welcome to this Henry Stewart Talk on cardiovascular prevention in type 2 diabetes. My name is Eberdhard Standl, and I'm working at the Munich Diabetes Research Group at the Helmholtz Center in Munich.
0:19
These are my disclosures.
0:24
We all know the clinical manifestations of atherothrombosis in people with type 2 diabetes are abundant, and particularly at heart, but also at the brain, at the peripheral arteries and also the renal arteries and the abdominal aorta.
0:52
Indeed it has been found that type 2 diabetes seems to be an equivalent of coronary artery disease. Now this has been based on this landmark study, at the so-called East West Study in Finland. We are looking here, and actually the study has been performed in the 1980s and early 1990s in Finland, so actually last century. And what we see here on the right side, diabetic patients with no prior myocardial infarction has a risk of around 20% over seven years from myocardial infarction, and this is more or less identical with risk in non diabetics with a prior myocardial infarction. So in other words, somebody with diabetes is at the same risk level than somebody without diabetes with a prior myocardial infarction. Of course, on the far right side, patients with diabetes and a prior myocardial infarction are at an enormously high risk.

Quiz available with full talk access. Request Free Trial or Login.

Show
Hide

Cardiovascular prevention in type 2 diabetes

Embed in course/own notes